Targeting 17β-estradiol biosynthesis in neural stem cells improves stroke outcome
Dax-1 (dosage-sensitive sex reversal adrenal hypoplasia congenital region on X-chromosome gene 1) blocks 17β-estradiol biosynthesis and its knockdown would be expected to increase 17β-estradiol production. We hypothesized that knockdown of Dax-1 in a conditionally immortalized neural stem cell (NSC)...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fncel.2022.917181/full |
_version_ | 1811288184087117824 |
---|---|
author | Shalmali Patkar Dafe Uwanogho Michel Modo Michel Modo Rothwelle J. Tate Robin Plevin Hilary V. O. Carswell |
author_facet | Shalmali Patkar Dafe Uwanogho Michel Modo Michel Modo Rothwelle J. Tate Robin Plevin Hilary V. O. Carswell |
author_sort | Shalmali Patkar |
collection | DOAJ |
description | Dax-1 (dosage-sensitive sex reversal adrenal hypoplasia congenital region on X-chromosome gene 1) blocks 17β-estradiol biosynthesis and its knockdown would be expected to increase 17β-estradiol production. We hypothesized that knockdown of Dax-1 in a conditionally immortalized neural stem cell (NSC) line, MHP36, is a useful approach to increase 17β-estradiol production. Short hairpin (sh) RNA targeted to Dax-1 in NSCs, namely MHP36-Dax1KD cells, resulted in the degradation of Dax-1 RNA and attenuation of Dax-1 protein expression. In vitro, MHP36-Dax1KD cells exhibited overexpression of aromatase and increased 17β-estradiol secretion compared to MHP36 cells. As 17β-estradiol has been shown to promote the efficacy of cell therapy, we interrogated the application of 17β-estradiol-enriched NSCs in a relevant in vivo disease model. We hypothesized that MHP36-Dax1KD cells will enhance functional recovery after transplantation in a stroke model. C57BL/6 male adult mice underwent ischemia/reperfusion by left middle cerebral artery occlusion for 45 min using an intraluminal thread. Two days later male mice randomly received vehicle, MHP36 cells, MHP36-Dax1KD cells, and MHP36 cells suspended in 17β-estradiol (100 nm) or 17β-estradiol alone (100 nm) with serial behavioral testing over 28 days followed by post-mortem histology and blinded analysis. Recovery of sensorimotor function was accelerated and enhanced, and lesion volume was reduced by MHP36-Dax1KD transplants. Regarding mechanisms, immunofluorescence indicated increased synaptic plasticity and neuronal differentiation after MHP36-Dax1KD transplants. In conclusion, knockdown of Dax-1 is a useful target to increase 17β-estradiol biosynthesis in NSCs and improves functional recovery after stroke in vivo, possibly mediated through neuroprotection and improved synaptic plasticity. Therefore, targeting 17β-estradiol biosynthesis in stem cells may be a promising therapeutic strategy for enhancing the efficacy of stem cell-based therapies for stroke. |
first_indexed | 2024-04-13T03:32:36Z |
format | Article |
id | doaj.art-61187a76e35041b3a5cd3c7189a35120 |
institution | Directory Open Access Journal |
issn | 1662-5102 |
language | English |
last_indexed | 2024-04-13T03:32:36Z |
publishDate | 2022-07-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Cellular Neuroscience |
spelling | doaj.art-61187a76e35041b3a5cd3c7189a351202022-12-22T03:04:25ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022022-07-011610.3389/fncel.2022.917181917181Targeting 17β-estradiol biosynthesis in neural stem cells improves stroke outcomeShalmali Patkar0Dafe Uwanogho1Michel Modo2Michel Modo3Rothwelle J. Tate4Robin Plevin5Hilary V. O. Carswell6Strathclyde Institute of Pharmacy and Biological Sciences, University of Strathclyde, Glasgow, United KingdomDepartment of Neuroscience, James Black Centre, King’s College London, London, United KingdomDepartment of Neuroscience, James Black Centre, King’s College London, London, United KingdomDepartment of Radiology, University of Pittsburgh, Pittsburgh, PA, United StatesStrathclyde Institute of Pharmacy and Biological Sciences, University of Strathclyde, Glasgow, United KingdomStrathclyde Institute of Pharmacy and Biological Sciences, University of Strathclyde, Glasgow, United KingdomStrathclyde Institute of Pharmacy and Biological Sciences, University of Strathclyde, Glasgow, United KingdomDax-1 (dosage-sensitive sex reversal adrenal hypoplasia congenital region on X-chromosome gene 1) blocks 17β-estradiol biosynthesis and its knockdown would be expected to increase 17β-estradiol production. We hypothesized that knockdown of Dax-1 in a conditionally immortalized neural stem cell (NSC) line, MHP36, is a useful approach to increase 17β-estradiol production. Short hairpin (sh) RNA targeted to Dax-1 in NSCs, namely MHP36-Dax1KD cells, resulted in the degradation of Dax-1 RNA and attenuation of Dax-1 protein expression. In vitro, MHP36-Dax1KD cells exhibited overexpression of aromatase and increased 17β-estradiol secretion compared to MHP36 cells. As 17β-estradiol has been shown to promote the efficacy of cell therapy, we interrogated the application of 17β-estradiol-enriched NSCs in a relevant in vivo disease model. We hypothesized that MHP36-Dax1KD cells will enhance functional recovery after transplantation in a stroke model. C57BL/6 male adult mice underwent ischemia/reperfusion by left middle cerebral artery occlusion for 45 min using an intraluminal thread. Two days later male mice randomly received vehicle, MHP36 cells, MHP36-Dax1KD cells, and MHP36 cells suspended in 17β-estradiol (100 nm) or 17β-estradiol alone (100 nm) with serial behavioral testing over 28 days followed by post-mortem histology and blinded analysis. Recovery of sensorimotor function was accelerated and enhanced, and lesion volume was reduced by MHP36-Dax1KD transplants. Regarding mechanisms, immunofluorescence indicated increased synaptic plasticity and neuronal differentiation after MHP36-Dax1KD transplants. In conclusion, knockdown of Dax-1 is a useful target to increase 17β-estradiol biosynthesis in NSCs and improves functional recovery after stroke in vivo, possibly mediated through neuroprotection and improved synaptic plasticity. Therefore, targeting 17β-estradiol biosynthesis in stem cells may be a promising therapeutic strategy for enhancing the efficacy of stem cell-based therapies for stroke.https://www.frontiersin.org/articles/10.3389/fncel.2022.917181/fullcerebral ischemiaestrogensteroidogenesiscell therapytransplantationneuroprotection |
spellingShingle | Shalmali Patkar Dafe Uwanogho Michel Modo Michel Modo Rothwelle J. Tate Robin Plevin Hilary V. O. Carswell Targeting 17β-estradiol biosynthesis in neural stem cells improves stroke outcome Frontiers in Cellular Neuroscience cerebral ischemia estrogen steroidogenesis cell therapy transplantation neuroprotection |
title | Targeting 17β-estradiol biosynthesis in neural stem cells improves stroke outcome |
title_full | Targeting 17β-estradiol biosynthesis in neural stem cells improves stroke outcome |
title_fullStr | Targeting 17β-estradiol biosynthesis in neural stem cells improves stroke outcome |
title_full_unstemmed | Targeting 17β-estradiol biosynthesis in neural stem cells improves stroke outcome |
title_short | Targeting 17β-estradiol biosynthesis in neural stem cells improves stroke outcome |
title_sort | targeting 17β estradiol biosynthesis in neural stem cells improves stroke outcome |
topic | cerebral ischemia estrogen steroidogenesis cell therapy transplantation neuroprotection |
url | https://www.frontiersin.org/articles/10.3389/fncel.2022.917181/full |
work_keys_str_mv | AT shalmalipatkar targeting17bestradiolbiosynthesisinneuralstemcellsimprovesstrokeoutcome AT dafeuwanogho targeting17bestradiolbiosynthesisinneuralstemcellsimprovesstrokeoutcome AT michelmodo targeting17bestradiolbiosynthesisinneuralstemcellsimprovesstrokeoutcome AT michelmodo targeting17bestradiolbiosynthesisinneuralstemcellsimprovesstrokeoutcome AT rothwellejtate targeting17bestradiolbiosynthesisinneuralstemcellsimprovesstrokeoutcome AT robinplevin targeting17bestradiolbiosynthesisinneuralstemcellsimprovesstrokeoutcome AT hilaryvocarswell targeting17bestradiolbiosynthesisinneuralstemcellsimprovesstrokeoutcome |